CS Paper Radar

CoPoE: Multimodal Fusion via Decomposable Disease-Coordinate Product-of-Experts for Missing-Modality Alzheimer's Diagnosis

Chihun An, Ikbeom Jang

cs.LG cs.CV ·submitted 2026-10-08 07:23 UTC · v1
publishedbenchmarkcode/data

Abstract

Multimodal Alzheimer's disease (AD) diagnosis benefits from integrating heterogeneous clinical, imaging, genomic, and biomarker evidence, but clinical cohorts frequently suffer from irregular modality missingness. Existing fusion methods often synthesize absent inputs, risking the introduction of artificial surrogates, or pool available signals into uninterpretable latent spaces. We present CoPoE (Disease-Coordinate Product-of-Experts), a disease-coordinate framework that maps multimodal evidence into a structured latent space partitioned into four distinct biological and clinical axes: genetic Risk, molecular Pathology, Neurodegeneration, and clinical Stage (R/P/N/S). Each observed modality parameterizes a diagonal Gaussian expert over the full RPNS vector, and a masked Product-of-Experts architecture fuses only the available modalities. Consequently, absent modalities add no factor to the fusion path, allowing the network to preserve a robust, decomposable posterior for any non-empty modality subset without synthetic imputation in the RPNS path. Through extensive missing-modality experiments on the ADNI dataset, CoPoE achieves the best all-modality performance and the highest mean AUROC across all 15 observed-subset evaluations among standardized missing-modality fusion baselines under a shared non-PET ADNI embedding benchmark, while substantially improving raw-probability ECE, Brier score, and NLL. Furthermore, PET-supervised probing shows evidence enrichment within the pathology (P) block under full modalities, with tau-related signal retained even when direct fluid biospecimen inputs are withheld. Our code is available at https://github.com/labhai/CoPoE.

Comment
Accepted at IEEE BIBM 2026

Closest papers

Nearest neighbours by meaning across the whole index.

Multimodal-Conditioned Latent Diffusion Models for Spatiotemporal Brain MRI Forecasting

cs.CV cs.AI ·2026-10-18 ·Antonio Scardace, Silvia Ingala, Sebastiano Battiato, Daniele Ravì
publishedcode/data similarity 0.71
Abstract · Accepted to WACV 2027

Spatiotemporal forecasting of 3D anatomical changes is a critical generative vision challenge for modeling Alzheimer's Disease (AD) progression. While brain MRI forecasting from single-modality data has advanced, other key complementary multimodal biomarkers remain underutilized. In this work, we propose the Multimodal-Conditioned Latent Diffusion Model (MC-LDM), a novel framework for patient-specific brain MRI synthesis. MC-LDM leverages multimodal biomarkers---MRI, tau-PET, Clinical Dementia Rating (CDR), and APOE4---during training, but relies only on baseline MRI, APOE4, and patient metadata at inference, reflecting realistic clinical availability. Our contributions are threefold: (1) a Latent Diffusion Model (LDM) fine-tuned via Low-Rank Adaptation (LoRA) for data-efficient learning; (2) a multimodal conditioning that integrates molecular and clinical signals to model heterogeneous disease trajectories; and (3) auxiliary predictors estimating unobserved multimodal biomarkers from MRI features and patient covariates to condition the diffusion model, removing the need for these assessments at inference. Trained on 1,355 visits from 852 subjects in the Alzheimer's Disease Neuroimaging Initiative (ADNI), MC-LDM reduces average regional volumetric MAE by 18% over the second-best baseline on an independent test set of 664 visits. To our knowledge, MC-LDM represents the first diffusion-based framework to leverage multimodal priors for MRI forecasting. This conceptual advancement enables patient-specific trajectory generation that captures aspects of AD heterogeneity not observable from structural anatomy alone, bridging the gap between rich multimodal supervision and the strict constraints of routine clinical deployment. Code is available at: https://github.com/antonioscardace/MC-LDM.

0.43

M$^2$PFN: End-to-End Disentangled Alignment for Generalizable Multimodal In-Context Learning in Alzheimer's Disease

cs.CV cs.AIcs.LG ·2026-09-23 ·Lujia Zhong, Shuo Huang, Jianwei Zhang, Xinyu Nie, Yonggang Shi
similarity 0.67
Abstract · Under review

While various multimodal methods combining imaging and tabular data for Alzheimer's disease (AD) diagnosis were proposed, they are often limited in generalization across cohorts. In-context learning (ICL) has demonstrated excellent generalization performances and high flexibility in foundational tabular models such as TabPFN. To extend TabPFN's ICL to multimodal AD analysis, the main obstacle is that TabPFN is meta-trained on synthetic tabular priors that do not naturally match the statistical structure of image-derived features. We propose M$^2$PFN, an end-to-end framework that turns this tabular foundation model into a multimodal AD predictor. M$^2$PFN (i) performs differentiable inference through TabPFN's transformer, back-propagating task gradients into 3D-MRI and tabular encoders; (ii) aligns the two modalities into a shared subspace, via disentanglement and a contrastive objective, matched to the ICL engine's prior; and (iii) folds in a frozen tabular-only prediction through a learnable gated shortcut. Because the ICL engine stays frozen, its in-context mechanism is preserved for test-time generalization, while end-to-end training shapes the encoders into features it can exploit. On ADNI ($n=2240$, three-class CN/MCI/AD), M$^2$PFN attains $65.55\%$ macro-F1 and $82.21\%$ macro-AUC, surpassing a comprehensive set of unimodal and multimodal baselines. By swapping only the head for a TabPFN regressor, the same architecture regresses baseline MMSE on a $1250$-subject sub-cohort to test MAE $1.743$, outperforming every multimodal baseline. On two external cohorts (OASIS-3 and SCAN) with no retraining, M$^2$PFN achieves the best AUC and the lowest MMSE MAE across all baselines, and transfers even when the cognitive instrument changes.

0.12

MSR-IVA: Masked Structural Residual Independent Vector Analysis for State-Aware Fusion of Structural MRI and Dynamic Functional Network Connectivity

cs.LG ·2026-08-25 ·Victor Solomon, Zening Fu, Rafal Angryk, Vince D. Calhoun, Jingyu Liu
published similarity 0.66
Abstract · Accepted at the 2026 IEEE International Workshop on Machine Learning for Signal Processing (MLSP 2026), Atlanta, GA, USA

Multimodal fusion of structural MRI (sMRI) and dynamic functional network connectivity (dFNC) can reveal how brain structure relates to changing functional states. When the same structural latent representation is coupled with multiple states, applying independent vector analysis (IVA) separately to each state can produce unrelated structural decompositions, while forcing identical decompositions may suppress state-specific relationships. In addition, not every subject expresses every dynamic state. We propose masked structural residual IVA (MSR-IVA), a state-aware framework that combines a shared structural representation with state-specific residual adaptations and masks for incomplete state expression. On an Alzheimer's Disease Neuroimaging Initiative cohort, MSR-IVA improved matched source coupling by 6.5% and reduced unmatched dependence by 15.7% relative to the independent pairwise IVA baseline. Among subjects expressing both states, mean absolute cross-state structural source correlation was 0.9177 for MSR-IVA versus 0.2978 for no sharing, demonstrating controlled structural sharing that preserves source correspondence while allowing state-specific adaptation.

0.24

TWIN-MoE: Two-stage Intra-Expert Imputation Network for Incomplete Multimodal Learning

cs.LG cs.AI ·2026-10-15 ·Liang Nathan Zheng, Jiyuan Liu, Wenhao Liang, Wei Emma Zhang, Weitong Chen +1 more
similarity 0.66
Abstract

Recent Mixture-of-Experts (MoE) approaches address missing modalities either by routing each missingness pattern to a dedicated expert, which scales poorly as the number of modalities grows, or by imputing the missing modality from representations contributed by multiple experts, which requires a costly retrieval mechanism. We show that routing induces expert-conditioned representation neighborhoods and derive an imputation-error bound controlled by their local feature dispersion. When these expert-conditioned neighborhoods are more compact than the global representation space, intra-expert aggregation admits a tighter worst-case reconstruction bound than unconstrained global aggregation. Guided by this analysis, we propose TWIN, a two-stage intra-expert imputation framework. Pre-imputation generates a context-conditioned estimate in the encoder embedding space and radially soft-clips it using modality-specific statistics maintained in an observed FIFO queue, this ensures that the pre-imputed modality stays in empirically calibrated region of the target modality space. Post-imputation refines the missing representation after MoE by aggregating expert-conditioned observed representations within the same sample. Across four missing-modality benchmarks under natural, random, and asymmetric dropout protocols, TWIN achieves state-of-the-art performance while using substantially fewer parameters than competing MoE-based imputation methods.

0.09

Generalist-Specialist Mixture-of-Experts for Rare Pathology Detection in Multimodal Imaging

cs.CV cs.AI ·2026-09-16 ·Johannes Kaiser, Florian Braunmiller, Daniel Rückert, Georgios Kaissis
similarity 0.66
Abstract

AI models for multimodal medical imaging must balance modality-specific specialization with cross-modal shared representations, a trade-off that pure Mixture-of-Experts (MoE) architectures currently fail to satisfy. Expert-based routing improves in-domain learning but may sacrifice cross-modal signals, which appear particularly important for rare (low-prevalence) pathologies in our experiments. To resolve this, we introduce Generalist-Specialist-MoE (GS-MoE), a two-branch (MoE) architecture that couples a cross-modal generalist model with distinct modality-specific specialists (experts) via domain-constrained feature fusion. On RadImageNet (1.35M images, 165 pathologies, three modalities), GS-MoE recovers detection of six low-prevalence pathologies on which every baseline scores F1 $=$ 0, with per-class gains up to +0.60 F1. It attains this while even slightly exceeding dense and specialist-only MoE aggregate baselines (MCC 0.770), while using ${\sim}53\%$ fewer active parameters at inference than the strongest investigated dense model.

0.12

Modality Contribution Score - A Per-Patient Framework for Quantifying the Relative Diagnostic Contribution of Structural MRI and Amyloid PET in Alzheimer's Disease

eess.IV cs.AIcs.CVcs.LG ·2026-08-23 ·Dawa Chyophel Lepcha, Aaliya Ali, Sophie A. Martin, Deepika Koundal, Pierrick Coupe +1 more
similarity 0.66
Abstract · 15 pages, 7 figures, Under review

Multimodal neuroimaging combining structural MRI and positron emission tomography (PET) captures complementary structure-function relationships across the Alzheimer's disease (AD) continuum, yet existing artificial intelligence systems produce a single diagnostic label without quantifying which imaging modality drove that decision for a specific patient. We introduce the Modality Contribution Network (MCNet) and the Modality Contribution Score (MCS), the first per-patient attribution framework quantifying the shift in modality dominance from structural atrophy to amyloid and metabolic dysfunction across the cognitively normal to MCI to AD continuum. MCS is normalised to unity per subject via modality ablation (MCS_MRI_i + MCS_PET_i = 1.0 for every subject i), providing an interpretable, clinically actionable score that fluid biomarkers cannot supply. Applied to 327 ADNI-3 participants balanced across cognitively normal, mild cognitive impairment, and AD groups, MCNet achieved competitive three-class staging performance (AUC=0.881). The MCS revealed a statistically significant monotonic gradient (Kruskal-Wallis p<0.0001), with increasing PET dominance from cognitively normal (MCS_PET 0.412+/-0.229) through MCI (0.489+/-0.289) to AD (0.671+/-0.426), validated against amyloid SUVR (r=0.172, p=0.006) and FDG metabolic biomarkers (r=-0.287, p=0.0005) from separate imaging pipelines. External replication in 1,073 independent OASIS-3 subjects confirmed cross-cohort generalisability (H=166.99, p<0.0001, eta^2=0.156). A mechanistic comparison with SHAP demonstrated that ablation-based MCS captures clinically meaningful modality dependence that deviation-based methods cannot. These findings position MCNet as a foundation for personalised imaging decisions, clinical trial stratification, and trustworthy AI in dementia care.

0.32

MMAP: Multimodal Missing-Aware Pretraining for Longitudinal Alzheimer's Prediction

cs.CV cs.LG ·2026-09-22 ·Fiona Kekwick, Matthew Baugh, Bernhard Kainz, Paul M. Matthews, Wenjia Bai
published similarity 0.65
Abstract · To be published in the proceedings of the 2026 MICCAI Workshop on Multimodal Learning with Medical Tabular Data

Clinical decision making heavily relies on predicting the disease progression trajectory by seeking to understand patient's health status which is characterised by multimodal medical data. AI holds great potential for learning useful representations from multimodal medical data to predict disease progression and aid clinical decision making. However, development of predictive AI models is constrained by missing modalities and incomplete tabular data frequently occurring in medical datasets. In addition, disease labels alone may only provide limited supervisory signals for learning representations from high-dimensional multimodal data. Here, we present MMAP, a novel Multimodal Missing-aware Alignment Pretraining method for learning image-tabular representations from incomplete data. An image encoder is pretrained with efficient sigmoid contrastive learning combined with generative reconstruction. A tabular encoder is built upon a tabular foundation model. A missing token generator enables the two encoders to take incomplete data as input, enabling the model to be robust against missing modalities, either with missing images or missing tabular data. We evaluate the clinical usefulness of the learnt multimodal representations on two challenging longitudinal clinical tasks for Alzheimer's disease: predicting disease stage conversion and predicting amyloid status. The proposed method outperforms strong multimodal and unimodal baselines.

0.26

Longitudinal Bayesian Learning of Continuous Disease Position across the Alzheimer's Disease Continuum

cs.LG cs.AIq-bio.QM ·2026-08-19 ·Yingying Zhang, Kun Zhao, Guodong Liu, Qi Huang, Pengfei Gu +8 more
similarity 0.65
Abstract

Alzheimer's disease (AD) progresses as a continuous biological process, whereas most existing neuroimaging-based artificial intelligence methods remain limited to discrete diagnosis or clinical score prediction from cross-sectional imaging. In this work, we propose Disease Continuum Positioning (DCP), a longitudinal Bayesian Learning framework that continuously estimates disease severity from longitudinal diffusion tensor imaging (DTI). Specifically, DCP models disease severity as a low-dimensional probabilistic latent variable by jointly integrating longitudinal observations with weak clinical supervision, from which the proposed Disease Continuum Score (DCS) is derived to quantify an individual's position along the Alzheimer's disease continuum together with its associated uncertainty. Extensive experiments on the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort demonstrate that DCP consistently outperforms representative disease progression methods. More importantly, comprehensive validation analyses show that DCS accurately characterizes disease severity, exhibits strong clinical relevance, preserves longitudinal disease evolution, and predicts future disease conversion. These results suggest that DCS provides a quantitative imaging-derived representation for continuous assessment of Alzheimer's disease progression beyond conventional diagnostic labels and clinical scores.

0.19